NIH | National Cancer Institute | NCI Wiki  

Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Owner(s)Action ItemDue DateStatus
Liz NessPull up example for when immunological response could be usedJul 10Open
Susan PannoniResearch immunological response - FDA considers this under biologic agentsJul 10Open
Liz NessTumor pathologic response - Uncover form and possible value list.  Lymphoma SME?Jul 10Open
Working GroupReview list of values for current response by disease distributed by Eleanor Leung-HollinsJul 10Open
Susan PannoniFollow up with outstanding action items list to see if anything still to be doneJul 10Open
Working GroupReview the new CDE Spreadsheet for the next meeting (ensure it covers the correct definitions and terms are correct)Jul 15Open
Working GroupReview the “updated” list of values for current response by disease distributed by Eleanor Leung-Hollins (with the feedback from Cathy)Jul 17Open
Susan PannoniAdd the immunological response list of values that are currently availableJul 17Open
Susan PannoniFigure out what list of values should be used for the “Site(s) of Relapse or Progression” elementJul 17Open
Working GroupReview the Prior and Post therapies to review if this includes the “Treatment Following Relapse or Progression” elementJul 17Open
Susan PannoniResearch “Did the Patient have PSA Progression” element further Jul 17OpenMary CooperAdd the updates from this meeting to the spreadsheetJul 17OpenGroup MembersFind any disease elements that are not already representedOngoingClosed

Working Group Documents

...